Related Experiment Video
Updated: May 4, 2026
The Successive Alleys Test of Anxiety in Mice and Rats
Published on: June 17, 2013
NMDA receptor activation antagonizes the NMDA antagonist-induced antianxiety effect in the elevated plus-maze test in
Ewa Poleszak1, Anna Serefko, Aleksandra Szopa
1Department of Applied Pharmacy, Medical University of Lublin, Chodźki 1, PL 20-093 Lublin, Poland. ewa.poleszak@umlub.pl.
Background:
The purpose of this study was to determine how the activation of different regulatory domains of the NMDA complex affects the antianxiety effect of antagonists acting at its distinct binding sites.
Methods:
The anxiolytic-like activity was assessed by the elevated plus-maze test in mice.
Results:
The anxiolytic activity of CGP 37849 (a competitive NMDA receptor antagonist) and L-701,324 (an antagonist at glycine site) was confirmed, but effects of both were significantly reduced by N-methyl-D-aspartic acid (NMDA) or by D-serine agonists at glutamate and glycine site of the NMDA receptor complex, respectively.
Conclusion:
The obtained data suggest that stimulation of the glutamate or glycine recognition site of the NMDA receptor complex significantly decreases the antianxiety properties of antagonists of either site.
